GC

George C. Petrocheilos

President at HealthCor Catalio Acquisition Corp. (NASDAQ: HCAQ)

New York, New York

Overview 

George C. Petrocheilos is the Co-Founder & Managing Partner at Catalio Capital Management, where he has successfully invested in companies like Clasp Therapeutics and DNA Script. With a background in finance and entrepreneurship, he has held roles such as President at HealthCor Catalio Acquisition Corp. and General Partner at Camden Partners, showcasing his expertise in private equity and portfolio management.

Work Experience 

  • Co-Founder & Managing Partner

    2020 - Current

    Founded Catalio in 2020, to invest exclusively in breakthrough life sciences companies around the globe, founded by the world's leading scientist-entrepreneurs.

Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies.

  • General Partner

    2014 - 2020

    Initially joined as an Analyst and then promoted to Partner at Camden Partners, a private equity firm that spun out of T. Rowe Price, where co-founded Camden Nexus, investing in breakthrough biomedical tech companies coming out of the labs of world-renowned scientist-entrepreneurs at Johns Hopkins.

Camden Partners provides growth capital to companies in the education, healthcare and technology-enabled business services sectors.

  • Analyst - Project Finance

    2011 - 2011

    Constellation Energy Group (former NYSE: CEG), was the only Baltimore-based Fortune 500 company. CEG was an energy producer, trader, and distributor that operated over 35 power plants and was one of the top electricity producers in the US. In 2012, it was acquired by (NYSE: EXC) for $7.9 billion.

Constellation Energy is a leading supplier of energy products and services to wholesale and retail electric and natural gas customers.

Articles About George

Relevant Websites